{
    "Rank": 819,
    "Study": {
        "ProtocolSection": {
            "IdentificationModule": {
                "NCTId": "NCT01063387",
                "OrgStudyIdInfo": {
                    "OrgStudyId": "GM2010-022"
                },
                "Organization": {
                    "OrgFullName": "Huazhong University of Science and Technology",
                    "OrgClass": "OTHER"
                },
                "BriefTitle": "Prophylactic Irradiation of the Para-Aortic Lymph Nodes and Supraclavicular Lymph Nodes in Locally Advanced Uterine Cervical Cancer",
                "OfficialTitle": "Molecular Markers in Lymph Node Metastasis of Cervical Cancer and Prophylactic Irradiation of the Para-Aortic Lymph Nodes and Supraclavicular Lymph Nodes in Locally Advanced Uterine Cervical Cancer"
            },
            "StatusModule": {
                "StatusVerifiedDate": "February 2010",
                "OverallStatus": "Unknown status",
                "LastKnownStatus": "Active, not recruiting",
                "ExpandedAccessInfo": {
                    "HasExpandedAccess": "No"
                },
                "StartDateStruct": {
                    "StartDate": "January 2010"
                },
                "PrimaryCompletionDateStruct": {
                    "PrimaryCompletionDate": "February 2015",
                    "PrimaryCompletionDateType": "Anticipated"
                },
                "CompletionDateStruct": {
                    "CompletionDate": "February 2015",
                    "CompletionDateType": "Anticipated"
                },
                "StudyFirstSubmitDate": "February 4, 2010",
                "StudyFirstSubmitQCDate": "February 4, 2010",
                "StudyFirstPostDateStruct": {
                    "StudyFirstPostDate": "February 5, 2010",
                    "StudyFirstPostDateType": "Estimate"
                },
                "LastUpdateSubmitDate": "February 4, 2010",
                "LastUpdatePostDateStruct": {
                    "LastUpdatePostDate": "February 5, 2010",
                    "LastUpdatePostDateType": "Estimate"
                }
            },
            "SponsorCollaboratorsModule": {
                "ResponsibleParty": {
                    "ResponsiblePartyOldNameTitle": "Ding Ma",
                    "ResponsiblePartyOldOrganization": "Cancer Biology Research Center of Tongji Hospital"
                },
                "LeadSponsor": {
                    "LeadSponsorName": "Huazhong University of Science and Technology",
                    "LeadSponsorClass": "OTHER"
                }
            },
            "OversightModule": {
                "OversightHasDMC": "Yes"
            },
            "DescriptionModule": {
                "BriefSummary": "This study is an open-label, randomized study, which is designed to investigate the efficacy of Extended-field irradiation (EFI) on reducing recurrences at the para-aortic lymph node (PAN) and supraclavicular lymph nodes, and also on improving disease-free survival of locally advanced uterine cervical cancer. This study includes a translational research component in that all the primary tumors and lymph node are stained with Sema4c, before randomization. According to the investigators study result, patients with more pelvic lymph node metastasis are more likely to develop distant metastasis including the recurrences at PAN and supraclavicular lymph node. Primary cervical cancer tissues and lymph nodes are examined for expression of Sema4c just after registration, and before the patients are randomized to each arm (pelvis only vs. EFI). The investigators expect a higher benefit of EFI in patients with Sema4c-positive lymph node."
            },
            "ConditionsModule": {
                "ConditionList": {
                    "Condition": [
                        "Cervical Cancer"
                    ]
                },
                "KeywordList": {
                    "Keyword": [
                        "cervical cancer,semaphorin 4C (Sema4C),",
                        "Prophylactic Irradiation"
                    ]
                }
            },
            "DesignModule": {
                "StudyType": "Interventional",
                "PhaseList": {
                    "Phase": [
                        "Phase 1"
                    ]
                },
                "DesignInfo": {
                    "DesignAllocation": "Randomized",
                    "DesignInterventionModel": "Parallel Assignment",
                    "DesignPrimaryPurpose": "Treatment",
                    "DesignMaskingInfo": {
                        "DesignMasking": "None (Open Label)"
                    }
                },
                "EnrollmentInfo": {
                    "EnrollmentCount": "200",
                    "EnrollmentType": "Anticipated"
                }
            },
            "ArmsInterventionsModule": {
                "ArmGroupList": {
                    "ArmGroup": [
                        {
                            "ArmGroupLabel": "Sema4c positive +Common iliac lymph nodes control",
                            "ArmGroupType": "No Intervention",
                            "ArmGroupDescription": "Sema4c Positive & \"Radical hysterectomy +Pelvic Radiotherapy \""
                        },
                        {
                            "ArmGroupLabel": "Sema4c positive +Common iliac lymph nodes Experimental",
                            "ArmGroupType": "Active Comparator",
                            "ArmGroupDescription": "Sema4c Positive & \"Radical hysterectomy+ EFI(whole pelvis + para-aortic lymph node irradiation) \"",
                            "ArmGroupInterventionList": {
                                "ArmGroupInterventionName": [
                                    "Radiation: Prophylactic Irradiation of the Para-Aortic Lymph Nodes and supraclavicular lymph nodes in Locally Advanced Uterine Cervical Cancer"
                                ]
                            }
                        },
                        {
                            "ArmGroupLabel": "Sema4c Positive + PAN positive control arm",
                            "ArmGroupType": "No Intervention",
                            "ArmGroupDescription": "Sema4c Positive & \" Radical hysterectomy+ EFI(whole pelvis + para-aortic lymph node irradiation) \""
                        },
                        {
                            "ArmGroupLabel": "Sema4c positive+ PAN positive Experimental",
                            "ArmGroupType": "Experimental",
                            "ArmGroupDescription": "Sema4c Positive & Radical hysterectomy+ EFI(whole pelvis + para-aortic lymph node irradiation+ supraclavicular lymph nodes irradiation) '",
                            "ArmGroupInterventionList": {
                                "ArmGroupInterventionName": [
                                    "Radiation: Prophylactic Irradiation of the Para-Aortic Lymph Nodes and supraclavicular lymph nodes in Locally Advanced Uterine Cervical Cancer"
                                ]
                            }
                        }
                    ]
                },
                "InterventionList": {
                    "Intervention": [
                        {
                            "InterventionType": "Radiation",
                            "InterventionName": "Prophylactic Irradiation of the Para-Aortic Lymph Nodes and supraclavicular lymph nodes in Locally Advanced Uterine Cervical Cancer",
                            "InterventionDescription": "Sema4c positive+ Para-aortic lymph node metastasis Experimental : Radiation: Extended-field Irradiation (EFI) Prophylactic irradiation of supraclavicular lymph node",
                            "InterventionArmGroupLabelList": {
                                "InterventionArmGroupLabel": [
                                    "Sema4c positive+ PAN positive Experimental"
                                ]
                            }
                        },
                        {
                            "InterventionType": "Radiation",
                            "InterventionName": "Prophylactic Irradiation of the Para-Aortic Lymph Nodes and supraclavicular lymph nodes in Locally Advanced Uterine Cervical Cancer",
                            "InterventionDescription": "Sema4c positive +Common iliac lymph nodes metastasis Experimental :Radical hysterectomy+ EFI(whole pelvis + para-aortic lymph node irradiation)",
                            "InterventionArmGroupLabelList": {
                                "InterventionArmGroupLabel": [
                                    "Sema4c positive +Common iliac lymph nodes Experimental"
                                ]
                            }
                        }
                    ]
                }
            },
            "OutcomesModule": {
                "PrimaryOutcomeList": {
                    "PrimaryOutcome": [
                        {
                            "PrimaryOutcomeMeasure": "To evaluate the efficacy of the Extended-Field Irradiation on the recurrence rate in para-aortic lymph nodes, supraclavicular lymph nodes and the disease-free survival rate of the patients with locally advanced uterine cervical cancer",
                            "PrimaryOutcomeTimeFrame": "5 years"
                        }
                    ]
                },
                "SecondaryOutcomeList": {
                    "SecondaryOutcome": [
                        {
                            "SecondaryOutcomeMeasure": "To evaluate overall survival, toxicities and quality of life (QOL) of the patients treated by EFI compared to the control group of patients",
                            "SecondaryOutcomeTimeFrame": "5 years"
                        }
                    ]
                }
            },
            "EligibilityModule": {
                "EligibilityCriteria": "Inclusion Criteria:\n\nPatients (who have been adequately clinically staged) with primary, untreated, histologically confirmed invasive squamous cell carcinoma, adenocarcinoma, or adenosquamous carcinoma of the uterine cervix, FIGO stage IB1 with pelvic lymph node metastasis, IB2, IIA(\u22654cm in tumor size, or pelvic LN metastasis), IIB, IIIA, IIIB? with only unilateral pelvic wall extension\nPatients with negative, para-aortic lymphadenopathy determined by pelvic MRI and/or PET/CT scan.\nPatients with adequate bone marrow function: ANC greater than or equal to 1,500/ul, platelets greater than or equal to 100,000/ul at the beginning.\nPatients with adequate renal function: creatinine equal to or less than 2.0 mg/dL.\nPatients who have signed an approved informed consent and authorization\nPatients with ECOG Performance Status of 0, 1, 2 and Karnofsky Performance Scale of 100, 90, 80, 70, 60, 50\nAge: 18\u2264age\u226480\n\nExclusion Criteria:\n\nStage IIIb with bilateral pelvic wall extension and stage IVB lesions are not eligible.\nPatients with histology other than squamous, adeno, adenosquamous cell carcinoma\nPatients who have received prior radiotherapy of pelvis or total hysterectomy Patients who have diagnosis of other malignant tumors other than non-malignant melanoma skin cancer or stage I. II papillary, follicular thyroid cancer.",
                "HealthyVolunteers": "No",
                "Gender": "Female",
                "MinimumAge": "18 Years",
                "MaximumAge": "80 Years",
                "StdAgeList": {
                    "StdAge": [
                        "Adult",
                        "Older Adult"
                    ]
                }
            },
            "ContactsLocationsModule": {
                "OverallOfficialList": {
                    "OverallOfficial": [
                        {
                            "OverallOfficialName": "Ma Ding, M.D.",
                            "OverallOfficialAffiliation": "Tongji Hospital of HUST",
                            "OverallOfficialRole": "Study Director"
                        }
                    ]
                },
                "LocationList": {
                    "Location": [
                        {
                            "LocationFacility": "Tongji Hospital of HUST",
                            "LocationCity": "Wuhan",
                            "LocationState": "Hubei",
                            "LocationCountry": "China"
                        }
                    ]
                }
            }
        },
        "DerivedSection": {
            "MiscInfoModule": {
                "VersionHolder": "September 08, 2023"
            },
            "ConditionBrowseModule": {
                "ConditionMeshList": {
                    "ConditionMesh": [
                        {
                            "ConditionMeshId": "D000002583",
                            "ConditionMeshTerm": "Uterine Cervical Neoplasms"
                        }
                    ]
                },
                "ConditionAncestorList": {
                    "ConditionAncestor": [
                        {
                            "ConditionAncestorId": "D000014594",
                            "ConditionAncestorTerm": "Uterine Neoplasms"
                        },
                        {
                            "ConditionAncestorId": "D000005833",
                            "ConditionAncestorTerm": "Genital Neoplasms, Female"
                        },
                        {
                            "ConditionAncestorId": "D000014565",
                            "ConditionAncestorTerm": "Urogenital Neoplasms"
                        },
                        {
                            "ConditionAncestorId": "D000009371",
                            "ConditionAncestorTerm": "Neoplasms by Site"
                        },
                        {
                            "ConditionAncestorId": "D000009369",
                            "ConditionAncestorTerm": "Neoplasms"
                        },
                        {
                            "ConditionAncestorId": "D000002577",
                            "ConditionAncestorTerm": "Uterine Cervical Diseases"
                        },
                        {
                            "ConditionAncestorId": "D000014591",
                            "ConditionAncestorTerm": "Uterine Diseases"
                        },
                        {
                            "ConditionAncestorId": "D000005831",
                            "ConditionAncestorTerm": "Genital Diseases, Female"
                        },
                        {
                            "ConditionAncestorId": "D000052776",
                            "ConditionAncestorTerm": "Female Urogenital Diseases"
                        },
                        {
                            "ConditionAncestorId": "D000005261",
                            "ConditionAncestorTerm": "Female Urogenital Diseases and Pregnancy Complications"
                        },
                        {
                            "ConditionAncestorId": "D000091642",
                            "ConditionAncestorTerm": "Urogenital Diseases"
                        },
                        {
                            "ConditionAncestorId": "D000091662",
                            "ConditionAncestorTerm": "Genital Diseases"
                        }
                    ]
                },
                "ConditionBrowseLeafList": {
                    "ConditionBrowseLeaf": [
                        {
                            "ConditionBrowseLeafId": "M11997",
                            "ConditionBrowseLeafName": "Neoplasm Metastasis",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M5520",
                            "ConditionBrowseLeafName": "Uterine Cervical Neoplasms",
                            "ConditionBrowseLeafAsFound": "Cervical Cancer",
                            "ConditionBrowseLeafRelevance": "high"
                        },
                        {
                            "ConditionBrowseLeafId": "M17032",
                            "ConditionBrowseLeafName": "Uterine Neoplasms",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M8635",
                            "ConditionBrowseLeafName": "Genital Neoplasms, Female",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M17005",
                            "ConditionBrowseLeafName": "Urogenital Neoplasms",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M5515",
                            "ConditionBrowseLeafName": "Uterine Cervical Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M17029",
                            "ConditionBrowseLeafName": "Uterine Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M8633",
                            "ConditionBrowseLeafName": "Genital Diseases, Female",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M2877",
                            "ConditionBrowseLeafName": "Genital Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M2876",
                            "ConditionBrowseLeafName": "Urogenital Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M26783",
                            "ConditionBrowseLeafName": "Female Urogenital Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M13817",
                            "ConditionBrowseLeafName": "Pregnancy Complications",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M8089",
                            "ConditionBrowseLeafName": "Female Urogenital Diseases and Pregnancy Complications",
                            "ConditionBrowseLeafRelevance": "low"
                        }
                    ]
                },
                "ConditionBrowseBranchList": {
                    "ConditionBrowseBranch": [
                        {
                            "ConditionBrowseBranchAbbrev": "BC04",
                            "ConditionBrowseBranchName": "Neoplasms"
                        },
                        {
                            "ConditionBrowseBranchAbbrev": "BC23",
                            "ConditionBrowseBranchName": "Symptoms and General Pathology"
                        },
                        {
                            "ConditionBrowseBranchAbbrev": "All",
                            "ConditionBrowseBranchName": "All Conditions"
                        },
                        {
                            "ConditionBrowseBranchAbbrev": "BXS",
                            "ConditionBrowseBranchName": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                        }
                    ]
                }
            }
        }
    }
}